Elastase 2, a key player in the integrity of the epidermal barrier and in Netherton syndrome;L'élastase 2, une nouvelle protéase épidermique impliquée dans l'établissement de la barrière cutanée

Medecine/Sciences

Volumn 26, Issue 8-9, 2010, Pages 681-685

  Bonnart, Chrystelle ^a,b   Deraison, Céline ^a,b   Lacroix, Matthieu ^a,b   Hovnanian, Alain ^a,c,d  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957322013     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2010268-9681     Document Type: Article

References (24)

1. Fuchs E. Scratching the surface of skin development Nature 2007; 445: 834-42.
2. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-40.
3. Caubet C, Jonca N, Brattsand M, et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/ hK7. J Invest Dermatol 2004; 122: 1235-44.
4. Kishibe M, Bando Y, Tetayama R, et al. Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins. J Biol Chem 2007; 282: 5834-41.
5. Stefansson K, Brattsand M, Ny A, et al. Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biol Chem 2006; 387: 761-8.
6. Borgono CA, Michael IP, Komatsu N, et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 2007; 282: 3640-52.
7. Bernard D, Mehul B, Thomas-Collignon A, et al. Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the socalled stratum corneum thiol protease as cathepsin 12. J Invest Dermatol 2003; 120: 592-600.
8. Igarashi S, Takizowa T, Yasudo Y, et al. Cathepsin D, but not cathepsin E, degrades desmosomes during epidermal desquamation. Br J Dermatol 2004; 151: 355-61.
9. Deraison C, Bonnart C, Lopez F, et al. LEKTI Fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biool Cell 2007; 18: 3607-19.
10. Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res 2000; 1: 87-92.
11. Schalkwijk J, de Roo C, de Jongh GJ. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties. Biochim Biophys Acta 1991; 1096: 148-54.
12. Zeeuwen PL, van Vlijmen-Willems IM, Olthuis D, et al. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice. Hum Mol Genet 2004; 13: 1069-79.
13. Komatsu N, Takata M, Otsuki N, et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 2002; 118: 436-43.
14. Cornel M. Ichtyosis linearis circumflexa. Dermatologica 1949; 98: 133-6.
15. Netherton EW. A unique case of Trichorrexis Invaginata. Arch Dermatol 1958; 78: 483-7.
16. Judge MR, Morgan G, Harper JL. A clinical and immunological study of Netherton's syndrome. Br J Dermatol 1994 131: 615-21.
17. Chavanos S, C Bodemer, A Rochat, et al., Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25: 141-2.
18. Bitoun E, Chavanas S, Irvine AD, et al. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 2002; 118: 352-61.
19. Bitoun E, Micheloni A, Lamant L, et al., LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet 2003; 12: 2417-30.
20. Descargues P, Deraison C, Bonnart C, et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005; 37: 56-65.
21. Bonnart C, Deraison C, Lacroix M, et al. Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 2010; 120: 871-82.
22. Swartzendruber DC, Wertz PW, Kitka DJ, et al. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J Invest Dermatol 1989; 92: 251-7.
23. Sandilands A, Sutherland C, Irvine AD, et al. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009; 122: 1285-94.
24. Descargues P, Deraison C, Bonnart C, Hovnanian A. Syndrome de Netherton : un modèle d'étude de la régulation de la desquamation. Med Sci (Paris) 2005; 21: 457-8.